Exclusion of Male Patients in Breast Cancer Clinical Trials-Reference-Cited by-同舟云学术

Exclusion of Male Patients in Breast Cancer Clinical Trials

Published:2018-04-01 Issue:2 Volume:2 Page:
ISSN:2515-5091
Container-title:JNCI Cancer Spectrum
language:en
Short-container-title:

Author:

Duma Narjust¹,Hoversten Katherine P²,Ruddy Kathryn J¹

Affiliation:

1. Medical Oncology, Mayo Clinic, Rochester, MN

2. Internal Medicine, Mayo Clinic, Rochester, MN

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jncics/article-pdf/2/2/pky018/28907488/pky018.pdf

Reference9 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program;Cardoso;Ann Oncol,2018

3. Three parallel randomized phase II trials of dasatinib plus hormone therapy (HT) in advanced ER+ breast cancer (ER+ ABC);Strauss;J Clin Oncol.,2010

4. Abstract PD7-10: Male-GBG54: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients;Reinisch;Cancer Res.,2018

5. Leuprolide acetate plus aromatase inhibition for male breast cancer;Giordano;J Clin Oncol.,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship;Current Oncology Reports;2024-01-02

2. Addressing Inequalities in Breast Cancer Care Delivery;Surgical Oncology Clinics of North America;2023-10

3. Revisiting Exclusion of Prior Cancer in Clinical Trials of Male Breast Cancer;Journal of Cancer;2023

4. A New Method of Identifying Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System;Annals of Surgical Oncology;2022-12-21

5. Nomogram for predicting distant metastasis of male breast cancer: A SEER population-based study;Medicine;2022-09-30